Physician profile
Sima Tabanfar
NPI 1528236502
$1,824.00
in general payments reported to CMS, 2019-2025
17 companies · $684 in 2025
The $684 reported for 2025 was more than what 84% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $280 · 2020: $68.18 · 2022: $216 · 2023: $264 · 2024: $312 · 2025: $684.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,259.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $356.89 | 2023-2025 | Kxl System (Not Refurbished), Radius |
| Novartis Pharmaceuticals Corporation | $257.38 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $171.41 | 2023-2025 | Envista Envy Iol, Miebo |
| Dompe US, INC. | $166.35 | 2022-2025 | Oxervate |
| Abbvie INC. | $151.65 | 2023-2025 | Vuity, Lumigan, Alphagan P |
| Lumenis Be INC | $129.11 | 2022 | |
| Rxsight INC | $83.85 | 2023-2025 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Revance Therapeutics, INC. | $77.11 | 2025 | Daxxify |
| Tarsus Pharmaceuticals, INC. | $72.48 | 2024-2025 | Xdemvy |
| Alcon Vision LLC | $66.76 | 2024-2025 | Clareon, Rocklatan |
| Johnson & Johnson Surgical Vision, INC. | $66.07 | 2024 | Tecnis Iol, Tecnis Simplicity |
| Biotissue Holdings INC. | $57.74 | 2022-2025 | |
| Shire North American Group INC | $53.08 | 2019 | |
| Eyevance Pharmaceuticals LLC | $50.35 | 2019-2020 | |
| Oyster Point Pharma, INC. | $25.19 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sun Pharmaceutical Industries INC. | $20.23 | 2019 | |
| Carl Zeiss Meditec, INC. | $18.35 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sima Tabanfar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.